Intended for healthcare professionals
Our Company
Subscribe
My Account
Login
Open main menu
covid-19
Research
Education
News & Views
Campaigns
Jobs
Archive
For authors
Hosted
Search
covid-19
Research
Education
News & Views
Campaigns
Jobs
Archive
For authors
Hosted
Search
Home
/
Research
/
Research methods & reporting
Research methods & reporting
Showing results 1-100
Sorted by:
Most recent
Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation
November 19, 2024
Reading and conducting instrumental variable studies
October 14, 2024
Recommendations on recording harms in randomised controlled trials of behaviour change interventions
October 2, 2024
Developing clinical prediction models: a step-by-step guide
September 3, 2024
Reporting on data sharing: executive position of the EQUATOR Network
August 13, 2024
Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration
July 9, 2024
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration
July 9, 2024
Exploring different objectives in non-inferiority trials
June 17, 2024
ROBVALU: a tool for assessing risk of bias in studies about people’s values, utilities, or importance of health outcomes
June 12, 2024
Guidance on terminology, application, and reporting of citation searching: the TARCiS statement
May 9, 2024
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
April 16, 2024
Quantifying possible bias in clinical and epidemiological studies with quantitative bias analysis: common approaches and limitations
April 2, 2024
Assessing robustness to worst case publication bias using a simple subset meta-analysis
March 15, 2024
Regression discontinuity design studies: a guide for health researchers
February 27, 2024
Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs
February 12, 2024
Updated recommendations for the Cochrane rapid review methods guidance for rapid reviews of effectiveness
February 6, 2024
Avoiding conflicts of interest and reputational risks associated with population research on food and nutrition
January 29, 2024
The estimands framework: a primer on the ICH E9(R1) addendum
January 23, 2024
Evaluation of clinical prediction models (part 3): calculating the sample size required for an external validation study
January 22, 2024
Evaluation of clinical prediction models (part 2): how to undertake an external validation study
January 15, 2024
Evaluation of clinical prediction models (part 1): from development to external validation
January 8, 2024
Emulation of a target trial using electronic health records and a nested case-control design
December 28, 2023
ROB-ME: a tool for assessing risk of bias due to missing evidence in systematic reviews with meta-analysis
November 20, 2023
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
October 20, 2023
Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
October 20, 2023
Understanding how health interventions or exposures produce their effects using mediation analysis
July 19, 2023
A guide and pragmatic considerations for applying GRADE to network meta-analysis
June 27, 2023
A framework for assessing selection and misclassification bias in mendelian randomisation studies: an illustrative example between BMI and covid-19
June 19, 2023
Practical thematic analysis: a guide for multidisciplinary health services research teams engaging in qualitative analysis
June 8, 2023
Selection bias due to conditioning on a collider
June 7, 2023
The imprinting effect of covid-19 vaccines: an expected selection bias in observational studies
June 7, 2023
A step-by-step approach for selecting an optimal minimal important difference
May 26, 2023
Recommendations for the development, implementation, and reporting of control interventions in trials of self-management therapies
May 25, 2023
Methods for deriving risk difference (absolute risk reduction) from a meta-analysis
May 5, 2023
Transparent reporting of multivariable prediction models for individual prognosis or diagnosis: checklist for systematic reviews and meta-analyses
May 3, 2023
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials
April 24, 2023
Transparent reporting of multivariable prediction models: : explanation and elaboration
February 7, 2023
Transparent reporting of multivariable prediction models: TRIPOD-Cluster checklist
February 7, 2023
Bias by censoring for competing events in survival analysis
September 13, 2022
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
August 29, 2022
Validation of prediction models in the presence of competing risks
May 24, 2022
Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence
May 18, 2022
Searching clinical trials registers: guide for systematic reviewers
April 26, 2022
How to design high quality acupuncture trials—a consensus informed by evidence
March 30, 2022
Early phase clinical trials extension to guidelines for the content of statistical analysis plans
February 7, 2022
Incorporating dose effects in network meta-analysis
January 18, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 statement
January 11, 2022
Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration
October 26, 2021
A new framework for developing and evaluating complex interventions
September 30, 2021
Adapting interventions to new contexts—the ADAPT guidance
August 3, 2021
Recommendations for including or reviewing patient reported outcome endpoints in grant applications
June 30, 2021
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration
April 30, 2021
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration
April 30, 2021
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data
April 30, 2021
Guidance for the design and reporting of studies evaluating the clinical performance of tests for present or past SARS-CoV-2 infection
March 29, 2021
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
March 29, 2021
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
March 29, 2021
Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration
March 15, 2021
Designing and undertaking randomised implementation trials: guide for researchers
January 18, 2021
STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies
January 12, 2021
Methodological standards for qualitative and mixed methods patient centered outcomes research
December 23, 2020
GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework
November 11, 2020
GRADE approach to drawing conclusions from a network meta-analysis using a partially contextualised framework
November 10, 2020
Use of multiple period, cluster randomised, crossover trial designs for comparative effectiveness research
November 4, 2020
When to replicate systematic reviews of interventions: consensus checklist
September 15, 2020
Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension
September 9, 2020
Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension
September 9, 2020
Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist
August 14, 2020
Non-adherence in non-inferiority trials: pitfalls and recommendations
July 1, 2020
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
June 17, 2020
Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness
March 20, 2020
Calculating the sample size required for developing a clinical prediction model
March 18, 2020
SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist
February 27, 2020
Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
January 16, 2020
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
October 23, 2019
A guide to prospective meta-analysis
October 9, 2019
RoB 2: a revised tool for assessing risk of bias in randomised trials
August 28, 2019
CONSORT 2010 statement: extension to randomised crossover trials
July 31, 2019
When and how to use data from randomised trials to develop or validate prognostic models
May 29, 2019
Guide to presenting clinical prediction models for use in clinical settings
April 17, 2019
A guide to systematic review and meta-analysis of prognostic factor studies
January 30, 2019
When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation
January 22, 2019
The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)
November 14, 2018
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
November 9, 2018
DELTA,2, guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
November 5, 2018
Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews
September 28, 2018
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
July 12, 2018
How to use FDA drug approval documents for evidence syntheses
July 10, 2018
How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider
May 25, 2018
TIDieR-PHP: a reporting guideline for population health and policy interventions
May 16, 2018
Analysis of cluster randomised trials with an assessment of outcome at baseline
March 20, 2018
Key design considerations for adaptive clinical trials: a primer for clinicians
March 8, 2018
Population attributable fraction
February 22, 2018
How to estimate the effect of treatment duration on survival outcomes using observational data
February 1, 2018
Concerns about composite reference standards in diagnostic research
January 18, 2018
Statistical methods to compare functional outcomes in randomized controlled trials with high mortality
January 3, 2018
CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials
November 23, 2017
Handling time varying confounding in observational research
October 16, 2017
Four study design principles for genetic investigations using next generation sequencing
October 12, 2017
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
September 21, 2017
Can’t find what you’re looking for?
Continue to all research methods & reporting articles